Echocardiographic evaluation of hypertrophic cardiomyopathy: A review of up-to-date knowledge and practical tips.
Ashraf M AnwarFolkert J tenCatePublished in: Echocardiography (Mount Kisco, N.Y.) (2021)
Hypertrophic cardiomyopathy (HCM) is the most frequent cardiac disease with genetic substrate, affecting about .2%-.5% of the population. The proper diagnosis is important for optimal management and follow-up. Echocardiography plays an essential role in the assessment of patients with HCM including diagnosis, screening, management formulation, prognosis, and follow up. It also helps to differentiate HCM from other diseases. The advancement of software and probe technology added many echo modalities and techniques that helped in refining the diagnostic and assessing the prognosis of patients with HCM. In this review, we briefly summarize how to integrate the different echocardiographic modalities to obtain comprehensive assessment supported by an updated knowledge of the latest guidelines and recently published articles. Many practical tips and tricks are included in this review to improve the diagnostic accuracy of echocardiography and minimize errors during interpretation.
Keyphrases
- hypertrophic cardiomyopathy
- left ventricular
- left atrial
- heart failure
- mitral valve
- healthcare
- magnetic resonance
- pulmonary hypertension
- drug delivery
- magnetic resonance imaging
- emergency department
- randomized controlled trial
- systematic review
- genome wide
- gene expression
- contrast enhanced
- data analysis
- single molecule
- drug induced